PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 1, 1995Clinical Pharmacology & Therapeutics183 citations

Success rates for new drugs entering clinical testing in the United States

View Full Paper
JDJoseph A. DiMasi

Key Points

Key points are not available for this paper at this time.

Abstract

Clinical Pharmacology doi: 10.1016/0009-9236(95)90066-7

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Joseph A. DiMasi (1995) studied this question.

synapsesocial.com/papers/6a711a8735aa2c282ce26c09https://doi.org/10.1016/0009-9236(95)90066-7
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Research and Development Costs for New Drugs by Therapeutic Category1995 · 170 citations
  2. 2Biopharmaceuticals and Conventional Drugs: Clinical Success Rates1992 · 37 citations
  3. 3Success rates in the United States drug development system1984 · 25 citations
  4. 4Market Structure and Technological Change2013 · 324 citations
  5. 5New drug development in the United States from 1963 to 19921994 · 73 citations